Persistence with urate-lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions.
Matthew James ColeshillRichard Osborne DayKarson TamMahsa KouhkamariVincent CailletEindra AungDiluk R W KannangaraPeter CroninAnthony RodgersSophie Lena StockerPublished in: British journal of clinical pharmacology (2022)
Persistence with allopurinol was poor. More effective methods targeting prescribers, patients and systems are required to promote persistence with allopurinol. Improving persistence to allopurinol is an important public health goal given the proven potential of this medication to eliminate gout.
Keyphrases
- public health
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- prognostic factors
- healthcare
- peritoneal dialysis
- emergency department
- stem cells
- risk assessment
- patient reported outcomes
- drug delivery
- adverse drug
- electronic health record
- drug induced
- patient reported
- smoking cessation
- replacement therapy